Difficulty: Medium
Average Score: 74%
Practice
What is the main reason for administering a progestational medication to perimenopausal women who use estrogen?
Correct answer
A
Rationale
The main reason for administering a progestational medication to perimenopausal women who use estrogen is to decrease the risk of endometrial hyperplasia. Estrogen alone can stimulate the growth of the endometrial lining, potentially leading to hyperplasia which is a risk factor for endometrial cancer. By adding a progestational medication, it counteracts estrogen's effect on the endometrium, leading to shedding of the lining and reducing the risk of hyperplasia.
Option A is correct because it directly addresses the main purpose of administering progestational medication in combination with estrogen therapy in perimenopausal women.
Option B, preventing hot flashes, is incorrect as progestational medication is not primarily used for this purpose. Hot flashes are more commonly managed with estrogen therapy alone.
Option C, preventing osteoporosis, is also incorrect as progestational medication does not have a direct role in preventing osteoporosis. Estrogen therapy is typically used for this purpose due to its beneficial effects on bone density.
Option D, promoting the growth of the uterine lining, is incorrect as this is the opposite of what progestational medication aims to do. Progestational medication works to counteract the proliferative effect of estrogen on the endometrium.
Understanding the rationale behind the use of progestational medication in combination with estrogen therapy is crucial for healthcare providers caring for perimenopausal women. It is essential to grasp the pharmacological actions of these medications to provide safe and effective care, minimize risks, and promote optimal health outcomes for patients.
Option A is correct because it directly addresses the main purpose of administering progestational medication in combination with estrogen therapy in perimenopausal women.
Option B, preventing hot flashes, is incorrect as progestational medication is not primarily used for this purpose. Hot flashes are more commonly managed with estrogen therapy alone.
Option C, preventing osteoporosis, is also incorrect as progestational medication does not have a direct role in preventing osteoporosis. Estrogen therapy is typically used for this purpose due to its beneficial effects on bone density.
Option D, promoting the growth of the uterine lining, is incorrect as this is the opposite of what progestational medication aims to do. Progestational medication works to counteract the proliferative effect of estrogen on the endometrium.
Understanding the rationale behind the use of progestational medication in combination with estrogen therapy is crucial for healthcare providers caring for perimenopausal women. It is essential to grasp the pharmacological actions of these medications to provide safe and effective care, minimize risks, and promote optimal health outcomes for patients.